Factors affecting antiretroviral therapy adherence among HIV-positive pregnant and postpartum women: an adapted systematic review

Vitalis, D
June 2013
International Journal of STD & AIDS;Jun2013, Vol. 24 Issue 6, p427
Academic Journal
Adherence to antiretroviral therapy (ART) is crucial for effective treatment, but can be quite complex. Non-adherence can adversely affect treatment outcomes. Although many studies have been done on adherence in the general population, few have included HIV-positive pregnant and postpartum women in resource-constrained settings. This review assessed the evidence on adherence among these groups of women. A systematic search of databases was completed between June and July 2011. Both qualitative and quantitative studies were included. Eighteen studies from a total of 6622 satisfied the inclusion criteria that included inter alia facilitators and barriers to adherence. This review highlighted that there is still no consensus on the definition and measurement of adherence; also multiple factors can affect a woman's ability to adhere to ART. Some of the barriers and facilitators identified were similar in both the type of study (qualitative and quantitative) and among the various countries. Findings indicated that the few studies in this population are conducted primarily in resource-rich settings. Such paucity of information warrants urgent attention; thus targeted research is needed to provide insight on adherence within this population.


Related Articles

  • Hierarchy of Determinants Underlying Death among HIV-Infected Patients in French Guiana. Hanf, Matthieu; Adenis, Antoine; Carme, Bernard; Couppié, Pierre; Nacher, Mathieu // Journal of AIDS & Clinical Research;2012, Vol. 3 Issue 7, Special section p1 

    Objective: In order to determine how risk factors of death among HIV-infected patients in French Guiana interact with one another and to deine high risk population segments, an alternative statistical method to Cox proportional hazards models was used. Patients and methods: Data from HIV+...

  • Innovative Policy to Prevent Mother-To-Child Transmission of HIV Shows Positive Impact.  // Chicago Citizen - South End Edition;3/13/2013, Vol. 46 Issue 6, p3 

    The article provides information on the success of a new treatment option, "Option B+," which offers lifelong antiretroviral treatment to pregnant or breastfeeding women infected with HIV and in turn prevents mother-to-child transmission of HIV.

  • The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study. Shafer, Leigh Anne; Nsubuga, Rebecca N.; Chapman, Ruth; O'Brien, Katie; Mayanja, Billy N.; White, Richard G. // Sexually Transmitted Infections;Aug2014, Vol. 90 Issue 5, p423 

    Objectives: Antiretroviral therapy (ART) availability in a population may influence risky sexual behaviour. We examine the potential impact of ART on the HIV epidemic, incorporating evidence for the impact that ART may have on risky sexual behaviour. Methods: A mathematical model, parameterised...

  • Editorial Commentary: Universal Antiretroviral Therapy for HIV Infection? Lundgren, Jens D.; Wood, Robin // Clinical Infectious Diseases;Sep2013, Vol. 57 Issue 6, p888 

    The article focuses on the benefit of antiretroviral therapy (ART) in the Human immunodeficiency virus (HIV) infected person under clinical trial conditions to stop the progression of HIV disease. It informs that untreated HIV infection activates host inflammatory processes which cause cancers....

  • Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study. Obel, Niels; Omland, Lars Haukali; Kronborg, Gitte; Larsen, Carsten S.; Pedersen, Court; Pedersen, Gitte; Sørensen, Henrik Toft; Gerstoft, Jan // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Background: We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDSdefining diseases, (2) comorbidity, and (3) drug and alcohol...

  • Transplacental Transfer of Antiretroviral Drugs and Newborn Birth Weight in HIV-Infected Pregnant Women. Ivanovic, Jelena; Nicastri, Emanuele; Anceschi, Maurizio M.; Ascenzi, Paolo; Signore, Fabrizio; Pisani, Giuseppe; Vallone, Cristina; Mattia, Elisabetta; Notari, Stefania; Tempestilli, Massimo; Pucillo, Leopoldo P.; Narciso, Pasquale // Current HIV Research;Nov2009, Vol. 7 Issue 6, p620 

    Although it is well known that antiretroviral drugs (ARVs) across the placenta in different extents, few data are available concerning the impact of the transplacental passage of ARVs on newborn outcome. The aim of this study is to evaluate the transplacental diffusion of ARVs and the clinical...

  • Incidence of Pregnancy after Initiation of Antiretroviral Therapy in South Africa: A Retrospective Clinical Cohort Analysis. Westreich, Daniel; Maskew, Mhairi; Rubel, Dennis; MacDonald, Pippa; Jaffray, Imogen; Majuba, Pappie // Infectious Diseases in Obstetrics & Gynecology;2012, p1 

    Background. Little is known about rates of incident pregnancy among HIV-positive women initiating highly active antiretroviral therapy (HAART). Methods. We conducted a retrospective clinical cohort study among therapy-naıve women ages 18-45 initiating HAART between 1 April 2004 and 30...

  • Incidence and Risk Factors of First-Line HAART Discontinuation: Is it Worth Choosing Competing Risk or Standard Survival Approaches? Keita, Momory; Chouquet, Cécile; Cuzin, Lise; Cissé, Mohamed; Lang, Thierry; Delpierre, Cyrille // Journal of AIDS & Clinical Research;2012, Vol. 3 Issue 10, Special section p1 

    Objectives: To estimate the incidences of first-line HAART discontinuation (for intolerance, treatment failure or treatment simplification) and their risk factors by standard survival (1-KM, Cox model) or competing risk approach (CIF, Fine-Gray model) in HIV infected patients. Methods: We...

  • An Update on HIV-associated Venous Thromboembolism in the Era of Highly Active Antiretroviral Therapy. Aboulafia, David M. // Journal of Coagulation Disorders;2010, Vol. 2 Issue 2, p1 

    HIV-associated morbidity and mortality have declined dramatically with the advent of highly active antiretroviral therapy (HAART). Prior to HAART, venous thromboembolism events (VTE) were infrequently described in HIV-infected patients. More recent epidemiologic surveys and case series suggest...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics